The influence of patient adherence on anticoagulation control with warfarin - Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study

被引:230
作者
Kimmel, Stephen E.
Chen, Zhen
Price, Maureen
Parker, Catherine S.
Metlay, Joshua P.
Christie, Jason D.
Brensinger, Colleen M.
Newcomb, Craig W.
Samaha, Frederick F.
Gross, Robert
机构
[1] Univ Penn, Sch Med, Dept Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[3] Philadelphia VA Med Ctr, Philadelphia, PA USA
关键词
D O I
10.1001/archinte.167.3.229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Warfarin sodium is a highly efficacious drug, but proper levels of anticoagulation are difficult to maintain. Conflicting data exist on the influence of patient adherence on anticoagulation control. Methods: We performed a prospective cohort study at 3 anticoagulation clinics to determine the effect of adherence on anticoagulation control. Patients treated with warfarin with a target international normalized ratio of 2.0 to 3.0 were monitored with electronic Medication Event Monitoring System (MEMS) medication bottle caps. Detailed information was collected on other factors that might alter warfarin response. Results: Among 136 participants observed for a mean of 32 weeks, 92% had at least 1 missed or extra bottle opening; 36% missedmorethan 20% of their bottle openings; and 4% had more than 10% extra bottle openings. In multivariable analyses, there was a significant association between under adherence and underanticoagulation. For each 10% increase in missed pill bottle openings, there was a 14% increase in the odds of underanticoagulation (P <. 001); participants with more than 20% missed bottle openings(1-2 missed days each week) had more than a 2-fold increase in the odds of underanticoagulation (adjusted odds ratio, 2.10; 95% confidence interval, 1.48-2.96). Participants who had extra pill bottle openings on more than 10% of days had a statistically significant increase in over anticoagulation (adjusted odds ratio, 1.73; 95% confidence interval, 1.09-2.74). Conclusion: Patients have substantial difficulties maintaining adequate adherence with warfarin regimens, and this poor adherence has a significant effect on anticoagulation control.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 26 条
[21]   TIME TO STOP COUNTING THE TABLETS [J].
PULLAR, T ;
KUMAR, S ;
TINDALL, H ;
FEELY, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) :163-168
[22]   Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose [J].
Rieder, MJ ;
Reiner, AP ;
Gage, BF ;
Nickerson, DA ;
Eby, CS ;
McLeod, HL ;
Blough, DK ;
Thummel, KE ;
Veenstra, DL ;
Rettie, AE .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22) :2285-2293
[23]  
Sullivan SD., 1990, J RES PHARMACO EC, V2, P19
[24]  
USDA Agricultural Research Service, USDA NAT NUTR DAT ST
[25]   The role of compliance as a cause of instability in oral anticoagulant therapy [J].
vanderMeer, FJM ;
Briet, E ;
Vandenbroucke, JP ;
Sramek, DI ;
Versluijs, MHPM ;
Rosendaal, FR .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (04) :893-900
[26]   Effect of warfarin nonadherence on control of the International Normalized Ratio [J].
Waterman, AD ;
Milligan, PE ;
Bayer, L ;
Banet, GA ;
Gatchel, SK ;
Gage, BF .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (12) :1258-1264